Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine
Authors
Keywords
chitosan nanoparticles, delivery systems, influenza virus, intranasal, split influenza vaccine
Journal
AAPS PHARMSCITECH
Volume 15, Issue 2, Pages 317-325
Publisher
American Association of Pharmaceutical Scientists (AAPS)
Online
2013-12-17
DOI
10.1208/s12249-013-0058-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Traditional and New Influenza Vaccines
- (2013) S.-S. Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- Comparison of immunogenicity and reactogenicity of split versus subunit influenza vaccine in Korean children aged 6–35 months
- (2013) Yun Kyung Kim et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Antibodies and Their Receptors: Different Potential Roles in Mucosal Defense
- (2013) Rachel E. Horton et al. Frontiers in Immunology
- Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge
- (2012) Xueliang Wang et al. ARCHIVES OF VIROLOGY
- Intranasal Immunization with a Formalin-Inactivated Human Influenza A Virus Whole-Virion Vaccine Alone and Intranasal Immunization with a Split-Virion Vaccine with Mucosal Adjuvants Show Similar Levels of Cross-Protection
- (2012) Shigefumi Okamoto et al. Clinical and Vaccine Immunology
- Vaccine delivery carriers: Insights and future perspectives
- (2012) J.F. Correia-Pinto et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Chitosan-based drug nanocarriers: Where do we stand?
- (2012) Marcos Garcia-Fuentes et al. JOURNAL OF CONTROLLED RELEASE
- Oily adjuvants and autoimmunity: now time for reconsideration?
- (2012) M Whitehouse LUPUS
- Dendritic Cell Targeted Chitosan Nanoparticles for Nasal DNA Immunization against SARS CoV Nucleocapsid Protein
- (2012) Dharmendra Raghuwanshi et al. MOLECULAR PHARMACEUTICS
- Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100
- (2012) Heng Liu et al. PLoS One
- Intranasal immunisation of mice against Streptococcus equi using positively charged nanoparticulate carrier systems
- (2012) L. Figueiredo et al. VACCINE
- Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly
- (2012) Roberto Gasparini et al. Human Vaccines & Immunotherapeutics
- Particulate vaccines: on the quest for optimal delivery and immune response
- (2011) Marie-Luce De Temmerman et al. DRUG DISCOVERY TODAY
- The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine
- (2011) Signe C. Svindland et al. Influenza and Other Respiratory Viruses
- Chitosan Microparticles and Nanoparticles as Biocompatible Delivery Vehicles for Peptide and Protein-Based Immunocontraceptive Vaccines
- (2011) Brendon Y. Chua et al. MOLECULAR PHARMACEUTICS
- Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
- (2011) Samuele Calabro et al. VACCINE
- Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
- (2010) Chunbai He et al. BIOMATERIALS
- Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant
- (2010) Zhiwei Sui et al. VACCINE
- Chitosan-based delivery systems for protein therapeutics and antigens
- (2009) Maryam Amidi et al. ADVANCED DRUG DELIVERY REVIEWS
- Chitosan-based formulations for delivery of DNA and siRNA
- (2009) Shirui Mao et al. ADVANCED DRUG DELIVERY REVIEWS
- Vaccination, squalene and anti-squalene antibodies: Facts or fiction?
- (2009) Giuseppe Lippi et al. European Journal of Internal Medicine
- Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery
- (2009) Noemi Csaba et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Low molecular weight chitosan in DNA vaccine delivery via mucosa
- (2009) Xiaorong Yang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
- (2009) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Physicochemical and Immunological Characterization of N,N,N-Trimethyl Chitosan-Coated Whole Inactivated Influenza Virus Vaccine for Intranasal Administration
- (2009) Niels Hagenaars et al. PHARMACEUTICAL RESEARCH
- Poly(γ-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice
- (2009) Shigefumi Okamoto et al. VACCINE
- Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions
- (2008) Anne Waschbisch et al. ARTHRITIS AND RHEUMATISM
- Pharmaceutical Aspects of Intranasal Delivery of Vaccines Using Particulate Systems
- (2008) Sameer Sharma et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started